Aug 14, 2024 08:01AM
Aug 13, 2024 08:01AM
Aug 6, 2024 08:01AM
Aug 6, 2024 08:01AM
Jul 30, 2024 08:02AM
Jul 30, 2024 08:01AM
Jun 26, 2024 09:07AM NeuroBo Pharmaceuticals (NRBO) Doses First Patient in the MAD Part 2 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
Jun 26, 2024 09:06AM
May 9, 2024 08:01AM
Mar 28, 2024 08:01AM
Mar 4, 2024 08:03AM
Mar 4, 2024 08:01AM
Feb 1, 2024 08:01AM
Feb 1, 2024 08:01AM NeuroBo Pharmaceuticals Announces FDA Clearance of IND for a Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity
Jan 18, 2024 08:01AM
Jan 18, 2024 08:01AM
Dec 28, 2023 08:45AM
Dec 28, 2023 08:45AM
Nov 13, 2023 04:05PM
Aug 9, 2023 04:05PM
Jun 27, 2023 08:07AM NeuroBo Pharmaceuticals' (NRBO) Novel GLP1R and GCGR Dual Agonist, DA-1726, Shown to Elicit Superior Weight Loss Efficacy Compared to Semaglutide and Tirzepatide in Preclinical Models
Jun 27, 2023 08:01AM
Jun 13, 2023 08:01AM
May 2, 2023 08:02AM
May 2, 2023 08:01AM
Apr 3, 2023 08:04AM
Apr 3, 2023 08:00AM
Oct 13, 2021 08:02AM NeuroBo Pharmaceuticals (NRBO) Announces Positive Recommendation from Independent Monitoring Committee of Phase 2/3 Clinical Trial of ANA001 in Hospitalized Patients with Moderate to Severe COVID-19
Oct 13, 2021 08:00AM
Apr 15, 2021 04:52PM
Mar 24, 2021 08:00AM
Jan 6, 2021 08:31AM
Jan 6, 2021 08:30AM
Nov 13, 2020 04:30PM
Aug 11, 2020 03:00PM NeuroBo Pharmaceuticals Reports Second Quarter 2020 Financial Results
Jun 15, 2020 06:36AM
May 26, 2020 08:37AM
May 26, 2020 08:30AM
May 20, 2020 04:29PM
Apr 21, 2020 08:34AM
Apr 21, 2020 08:30AM
Mar 30, 2020 04:30PM NeuroBo Pharmaceuticals Reports Year End 2019 Financial Results and Provides Corporate Strategic Update
Jan 10, 2020 05:00PM

322,950 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All